Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sruthi Ravindranathan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Expert Review of Vaccines|October 14, 2014
Current status of autologous breast tumor cell-based vaccinesSamantha L Kurtz, Sruthi Ravindranathan, David A Zaharoff
Marine Drugs|May 18, 2016
Effect of Chitosan Properties on ImmunoreactivitySruthi Ravindranathan, Bhanu Prasanth Koppolu, Sean G Smith, et al.
Oncoimmunology|February 16, 2017
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancerSean G Smith, John L Baltz, Bhanu Prasanth Koppolu, et al.
Biomaterials|February 25, 2014
Controlling chitosan-based encapsulation for protein and vaccine deliveryBhanu Prasanth Koppolu, Sean G Smith, Sruthi Ravindranathan, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2015
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancerSean G Smith, Bhanu Prasanth Koppolu, Sruthi Ravindranathan, et al.
Oncoimmunology|May 13, 2015
Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasisJimmy Ln Vo, Lirong Yang, Samantha L Kurtz, et al.
International Journal of Molecular Sciences|December 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case ReportChristopher Ronald Funk, Christopher T Petersen, Neera Jagirdar, et al.
Frontiers in Immunology|May 8, 2023
The magic of small-molecule drugs during <i>ex vivo</i> expansion in adoptive cell therapyHanwen Zhang, Tenzin Passang, Sruthi Ravindranathan, et al.
Breast Cancer Research : BCR|October 24, 2018
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccinesSruthi Ravindranathan, Khue G Nguyen, Samantha L Kurtz, et al.
American Journal of Infection Control|October 28, 2022
Passenger pathogens on physiciansChristopher Ronald Funk, Sruthi Ravindranathan, Alex Matelski, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Expert Review of Vaccines|October 14, 2014
Current status of autologous breast tumor cell-based vaccinesSamantha L Kurtz, Sruthi Ravindranathan, David A Zaharoff
Marine Drugs|May 18, 2016
Effect of Chitosan Properties on ImmunoreactivitySruthi Ravindranathan, Bhanu Prasanth Koppolu, Sean G Smith, et al.
Oncoimmunology|February 16, 2017
Immunological mechanisms of intravesical chitosan/interleukin-12 immunotherapy against murine bladder cancerSean G Smith, John L Baltz, Bhanu Prasanth Koppolu, et al.
Biomaterials|February 25, 2014
Controlling chitosan-based encapsulation for protein and vaccine deliveryBhanu Prasanth Koppolu, Sean G Smith, Sruthi Ravindranathan, et al.
Cancer Immunology, Immunotherapy : CII|March 11, 2015
Intravesical chitosan/interleukin-12 immunotherapy induces tumor-specific systemic immunity against murine bladder cancerSean G Smith, Bhanu Prasanth Koppolu, Sruthi Ravindranathan, et al.
Oncoimmunology|May 13, 2015
Neoadjuvant immunotherapy with chitosan and interleukin-12 to control breast cancer metastasisJimmy Ln Vo, Lirong Yang, Samantha L Kurtz, et al.
International Journal of Molecular Sciences|December 22, 2018
Oligoclonal T Cells Transiently Expand and Express Tim-3 and PD-1 Following Anti-CD19 CAR T Cell Therapy: A Case ReportChristopher Ronald Funk, Christopher T Petersen, Neera Jagirdar, et al.
Frontiers in Immunology|May 8, 2023
The magic of small-molecule drugs during <i>ex vivo</i> expansion in adoptive cell therapyHanwen Zhang, Tenzin Passang, Sruthi Ravindranathan, et al.
Breast Cancer Research : BCR|October 24, 2018
Tumor-derived granulocyte colony-stimulating factor diminishes efficacy of breast tumor cell vaccinesSruthi Ravindranathan, Khue G Nguyen, Samantha L Kurtz, et al.
American Journal of Infection Control|October 28, 2022
Passenger pathogens on physiciansChristopher Ronald Funk, Sruthi Ravindranathan, Alex Matelski, et al.
Pageof 2